Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Pivot Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Target Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Query: UMLS:C0023890 (
cirrhosis
)
42,195
document(s) hit in 31,850,051 MEDLINE articles (0.00 seconds)
Arylsulfatase (
ASA
) enzyme deficiency is associated with metachromatic leukodystrophy (MLD), which is a hereditary myelin metabolic disease. It has been proposed that in alcoholic subjects with abnormal
ASA
, the accumulation of sulfatides may lead to demyelinization and generalized cerebral atrophy.
ASA
may be diminished in subjects with alcoholic cirrhosis having encephalopathic manifestations. This idea has not been previously proposed. Leukocyte arylsulfatase A (ASA) activity was measured in 30 healthy male volunteers and 28 patients with alcohol-related
cirrhosis
. The patients were divided into two groups: patients with alcohol-related
cirrhosis
with hepatic encephalopathy history and patients with alcoholic cirrhosis without history of hepatic encephalopathy. Alcoholic cirrhotic patients with history of encephalopathy showed 58.21% (40.95 nmol/mg protein/h) less enzymatic activity than a control group (98.00 nmol/mg protein/h), whereas the group without history of encephalopathy showed an
ASA
value which was 38.2% (60.55 nmol/mg protein/h) less than the control group. The results suggest that the low
ASA
activity is a factor associated to the appearance of encephalopathy in patients with alcohol-related
cirrhosis
.
...
PMID:Leukocyte arylsulfatase A activity in patients with alcohol-related cirrhosis. 1146 Aug 94